| 1 |
28662341 | A Phase II Study of the c-Met Inhibitor Tivantinib in Combination with FOLFOX for the Treatment of Patients with Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction, or Stomach. | 2017 Aug 9 |
2 |
| 2 |
25711511 | Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors. | 2015 May |
2 |
| 3 |
26123926 | Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer. | 2015 Oct |
1 |